Outlook Therapeutics, Inc. (OTLK) Financials
OTLK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 21.9 trillion | 50.9 trillion |
| Dec. 31, 2025 | 18.2 million | 56.8 million |
| Sept. 30, 2025 | 18.6 million | 50.8 million |
| June 30, 2025 | 22.4 million | 59.6 million |
OTLK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -7.8 trillion | 757.5 billion |
| Dec. 31, 2025 | -14.9 trillion | 881.2 billion |
| Sept. 30, 2025 | -12.4 million | 1.8 million |
| June 30, 2025 | -11.9 million | 1.7 million |
OTLK Net Income
No data available :(
OTLK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 7.7 trillion | 157.0 billion | 156958 |
| Dec. 31, 2025 | 8.7 million | - | 233113 |
| Sept. 30, 2025 | 8.1 million | - | 247698 |
| June 30, 2025 | 8.9 million | 20.4 million | 260705 |
OTLK Shares Outstanding
OTLK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 4.5 million | 9.5 million | - |
| Dec. 31, 2025 | - | 3.6 million | 8.6 million | - |
| Sept. 30, 2025 | - | 6.0 million | 10.3 million | - |
| June 30, 2025 | - | 7.1 million | 9.7 million | - |
OTLK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 127439 | 179744 |
| Dec. 31, 2025 | -1.2 million | 29626 |
| Sept. 30, 2025 | -91787 | 916515 |
| June 30, 2025 | 1.5 million | 439815 |
OTLK
Price: $1.58
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 308347
Market Capitalization: 30.6 million